HU911303D0 - Process for the production of actinobacillus pleuropneumoniae vaccine - Google Patents
Process for the production of actinobacillus pleuropneumoniae vaccineInfo
- Publication number
- HU911303D0 HU911303D0 HU911303A HU130391A HU911303D0 HU 911303 D0 HU911303 D0 HU 911303D0 HU 911303 A HU911303 A HU 911303A HU 130391 A HU130391 A HU 130391A HU 911303 D0 HU911303 D0 HU 911303D0
- Authority
- HU
- Hungary
- Prior art keywords
- production
- actinobacillus pleuropneumoniae
- vaccine
- pleuropneumoniae vaccine
- actinobacillus
- Prior art date
Links
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP90200989 | 1990-04-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU911303D0 true HU911303D0 (en) | 1991-10-28 |
| HUT61489A HUT61489A (en) | 1993-01-28 |
| HU211031B HU211031B (en) | 1995-09-28 |
Family
ID=8204998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU911303A HU211031B (en) | 1990-04-20 | 1991-04-19 | Method for preparation of actinobacillus pleuropneumoniae vaccine |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5648081A (hu) |
| EP (1) | EP0453024B1 (hu) |
| JP (1) | JP3240063B2 (hu) |
| KR (1) | KR100196208B1 (hu) |
| CN (1) | CN1055024C (hu) |
| AU (1) | AU634879B2 (hu) |
| CA (1) | CA2040544C (hu) |
| DE (1) | DE69110082T2 (hu) |
| DK (1) | DK0453024T3 (hu) |
| ES (1) | ES2075325T3 (hu) |
| GR (1) | GR3017160T3 (hu) |
| HU (1) | HU211031B (hu) |
| NZ (1) | NZ237867A (hu) |
| ZA (1) | ZA912796B (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0563288B1 (en) * | 1990-12-19 | 1999-03-03 | Pfizer Inc. | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines |
| US5994525A (en) | 1991-06-28 | 1999-11-30 | Kamp; Elbarte Margriet | Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins |
| US5417971A (en) * | 1991-10-22 | 1995-05-23 | University Of Saskatchewan | Vaccines for Actinobacillus pleuropneumoniae |
| AU4114893A (en) * | 1992-04-27 | 1993-11-29 | Michigan State University | Method for producing a bacterial vaccine and novel vaccines produced thereby |
| US6656477B1 (en) * | 1992-07-28 | 2003-12-02 | Board Of Trustees Of Michigan State University | 43 Kd protein vaccine and method for the production thereof |
| CA2170839A1 (en) * | 1995-03-01 | 1996-09-02 | Janet Macinnes | Bacterial preparations, method for producing same, and their use as vaccines |
| US5925354A (en) | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| US6342231B1 (en) | 1998-07-01 | 2002-01-29 | Akzo Nobel N.V. | Haemophilus parasuis vaccine and diagnostic |
| US6713071B1 (en) | 1998-10-22 | 2004-03-30 | Pfizer Inc. | Proteins from actinobacillus pleuropneumoniae |
| TWI224107B (en) * | 1998-10-22 | 2004-11-21 | Pfizer Prod Inc | Novel proteins from actinobacillus pleuropneumoniae |
| KR100372278B1 (ko) * | 2000-03-03 | 2003-02-17 | 주식회사 한국미생물연구소 | 돼지 호흡기용 혼합백신 |
| WO2003076643A2 (en) * | 2002-02-25 | 2003-09-18 | U.S. Army Medical Research And Materiel Command | Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| TWI461529B (zh) | 2008-11-27 | 2014-11-21 | Intervet Int Bv | 產製RTX毒素ApxI之方法 |
| TWI392737B (zh) | 2008-11-27 | 2013-04-11 | Intervet Int Bv | 產製RTX毒素ApxI或ApxIII 之方法 |
| TWI548746B (zh) | 2009-08-06 | 2016-09-11 | 英特威特國際股份有限公司 | 防備豬胸膜肺炎之疫苗及製備該疫苗之方法 |
| CN102058880B (zh) * | 2010-10-13 | 2012-11-21 | 青岛易邦生物工程有限公司 | 猪传染性胸膜肺炎三价灭活疫苗的生产方法 |
| ES2416154B1 (es) | 2011-11-09 | 2015-04-01 | Laboratorios Hipra, S.A. | Cepa viva atenuada de Actinobacillus pleuropneumoniae |
| KR101491792B1 (ko) * | 2013-09-10 | 2015-02-13 | 대한민국 | 신규한 액티노바실러스 플로르뉴모니아 혈청형 5번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물 |
| KR101491803B1 (ko) * | 2013-09-10 | 2015-02-16 | 대한민국 | 신규한 액티노바실러스 플로르뉴모니아 혈청형 2번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물 |
| CN104502581B (zh) * | 2014-12-07 | 2016-05-04 | 青岛易邦生物工程有限公司 | 一种猪传染性胸膜肺炎抗体检测用抗原及制备方法 |
| KR101818901B1 (ko) | 2016-08-26 | 2018-01-16 | 우진 비앤지 주식회사 | 돼지흉막폐렴균의 재조합 ApxIA, ApxIIA, ApxIIIA toxin의 N 또는 C 말단 분자 및 불활화 돼지흉막폐렴균을 이용한 돼지 흉막폐렴 백신 조성물 |
| EP3689373A1 (en) | 2019-01-30 | 2020-08-05 | IDT Biologika GmbH | Inactivated apxia, apxiia and apxiiia toxins |
| GB202011902D0 (en) | 2020-07-30 | 2020-09-16 | Imperial College Innovations Ltd | Antinobacillus pleuropneumoniae vaccines |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK138379A (da) * | 1979-04-04 | 1980-10-05 | Nordisk Droge & Kemikalie | Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae |
| US5047237A (en) * | 1985-09-06 | 1991-09-10 | Prutech Research And Development Partnership | Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
| NL8802007A (nl) * | 1988-08-12 | 1990-03-01 | Centraal Diergeneeskundig Inst | Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins. |
| US5641653A (en) * | 1989-10-31 | 1997-06-24 | The Texas A&M University System | DNA encoding Actinobacillus pleuropneumoniae hemolysin |
-
1991
- 1991-04-11 EP EP91200849A patent/EP0453024B1/en not_active Expired - Lifetime
- 1991-04-11 ES ES91200849T patent/ES2075325T3/es not_active Expired - Lifetime
- 1991-04-11 DE DE69110082T patent/DE69110082T2/de not_active Expired - Lifetime
- 1991-04-11 DK DK91200849.7T patent/DK0453024T3/da active
- 1991-04-15 ZA ZA912796A patent/ZA912796B/xx unknown
- 1991-04-16 CA CA002040544A patent/CA2040544C/en not_active Expired - Lifetime
- 1991-04-18 NZ NZ237867A patent/NZ237867A/xx unknown
- 1991-04-19 CN CN91103236A patent/CN1055024C/zh not_active Expired - Lifetime
- 1991-04-19 KR KR1019910006414A patent/KR100196208B1/ko not_active Expired - Fee Related
- 1991-04-19 JP JP18061791A patent/JP3240063B2/ja not_active Expired - Lifetime
- 1991-04-19 HU HU911303A patent/HU211031B/hu unknown
- 1991-04-19 AU AU75192/91A patent/AU634879B2/en not_active Expired
-
1995
- 1995-01-03 US US08/367,908 patent/US5648081A/en not_active Expired - Lifetime
- 1995-08-22 GR GR950402268T patent/GR3017160T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04225924A (ja) | 1992-08-14 |
| CN1055024C (zh) | 2000-08-02 |
| KR100196208B1 (ko) | 1999-06-15 |
| KR910018033A (ko) | 1991-11-30 |
| NZ237867A (en) | 1992-11-25 |
| US5648081A (en) | 1997-07-15 |
| CN1056428A (zh) | 1991-11-27 |
| GR3017160T3 (en) | 1995-11-30 |
| EP0453024B1 (en) | 1995-05-31 |
| HUT61489A (en) | 1993-01-28 |
| DK0453024T3 (da) | 1995-10-16 |
| CA2040544A1 (en) | 1991-10-21 |
| DE69110082D1 (de) | 1995-07-06 |
| JP3240063B2 (ja) | 2001-12-17 |
| ES2075325T3 (es) | 1995-10-01 |
| HU211031B (en) | 1995-09-28 |
| EP0453024A1 (en) | 1991-10-23 |
| ZA912796B (en) | 1992-01-29 |
| CA2040544C (en) | 2002-10-22 |
| DE69110082T2 (de) | 1995-11-09 |
| AU7519291A (en) | 1991-11-21 |
| AU634879B2 (en) | 1993-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU911303D0 (en) | Process for the production of actinobacillus pleuropneumoniae vaccine | |
| HU913595D0 (en) | Process for the production of tnf-muteines | |
| HU913664D0 (en) | Process for the production of indian- and kinoline derivatives | |
| EP0441235A3 (en) | Process for the continuous preparation of imidoperoxycarbonic acids | |
| ZA915786B (en) | Process for the manufacture of biphenylcarbonitriles | |
| HU912005D0 (en) | Process for the production of aminobenzodiazepines | |
| EP0448194A3 (en) | Process for production of polyarylenesulfides | |
| HU913290D0 (en) | Process for the production of cyuclodextrines | |
| HU910151D0 (en) | Process for the production of substituted 2-chloride-pyridines | |
| HU9200933D0 (en) | Process for the production of kinoline derivatives | |
| HU9102385D0 (en) | Process for the production of medical preparations | |
| HU913280D0 (en) | Process for the production of 8-chloro-kinoline derivatives | |
| HU910937D0 (en) | Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives | |
| ZA915396B (en) | Process for the preparation of 1-hydroxymethylpyrazoles | |
| EP0439745A3 (en) | Process for the preparation of 2-chloro-5-methyl-pyridine | |
| HU912085D0 (en) | Process for the production of glycine | |
| EP0444460A3 (en) | Process for the preparation of acrolin | |
| EP0449778A3 (en) | Process for the preparation of hydroxyphenylepropionates | |
| IL97512A0 (en) | Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles | |
| HUT65728A (en) | Improved process for the production of glycosil-transpherases | |
| IL98877A0 (en) | Process for the preparation of n-alkylsulfonylamino-sulfonylureas | |
| IL100132A0 (en) | Process for the production of decabromodiphenylalkane | |
| HU910729D0 (en) | Process for producing pharmaceutical preparatives of anti-progestomime effect | |
| IL98876A0 (en) | Process for the preparation of n-alkylsulfonyl aminosulfonylureas | |
| EP0459242A3 (en) | Process for the preparation of phenolethers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: INTERVET INTERNATIONAL B.V., NL Free format text: FORMER OWNER(S): AKZO N.V., NL |